Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Co-Diagnostics Community
NasdaqCM:CODX Community
3
Narratives
written by author
1
Comments
on narratives written by author
14
Fair Values set
on narratives written by author
Community Investing Ideas
Co-Diagnostics
Popular
Undervalued
Overvalued
Co-Diagnostics
AN
AnalystLowTarget
Consensus Narrative from 1 Analyst
Revenue Drops And Regulatory Delays Will Spark A Cautious Rebound
Key Takeaways High execution risk and regulatory uncertainty threaten the company's ability to turn innovation into timely commercial gains, while persistent losses pressure financial sustainability. Intense competition, pricing pressures, and regulatory compliance challenges may hamper expansion, reduce margins, and limit market penetration in both domestic and international markets.
View narrative
US$1.00
FV
68.1% undervalued
intrinsic discount
279.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Co-Diagnostics
AN
AnalystHighTarget
Consensus Narrative from 1 Analyst
Decentralized Diagnostics Will Expand Global Infectious Disease Surveillance
Key Takeaways Rapid global market expansion, local partnerships, and broad clinical trial efforts could accelerate revenue growth and create significant first-mover advantages. Unique cloud-connected platforms and diversified product offerings enable recurring premium revenue streams, improved margins, and resilience beyond pandemic-driven demand.
View narrative
US$10.00
FV
96.8% undervalued
intrinsic discount
278.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Co-Diagnostics
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Regulatory Approvals And Launches Will Expand Decentralized Healthcare Access
Key Takeaways Entry into high-need global markets and decentralized testing supports sustained growth, recurring revenue, and broader healthcare impact through advanced diagnostic solutions. Proprietary platforms and strategic partnerships drive customer retention, efficiency, and market penetration while mitigating financial risks during commercialization.
View narrative
US$5.50
FV
94.2% undervalued
intrinsic discount
186.13%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
4
users have followed this narrative
9 days ago
author updated this narrative
Your Valuation for
CODX
CODX
Co-Diagnostics
Your Fair Value
US$
Current Price
US$0.32
30.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-76m
96m
2015
2018
2021
2024
2025
2027
2030
Revenue US$16.3m
Earnings US$2.3m
Advanced
Set Fair Value